Cargando…
Tumor containing fragment number influences immunohistochemistry positive rate of HER2 in biopsy specimens of gastric cancer
BACKGROUND: HER2 assessment in biopsy specimens of gastric cancer (GC) is challenging because of the intratumoral heterogeneity. False negative results may be get because of limited biopsy material. The aim of this study is to explore how tumor-containing fragment number and biopsy specimen number a...
Autores principales: | Xu, Chen, Liu, Yalan, Ge, Xiaowen, Jiang, Dongxian, Zhang, Ying, Ji, Yuan, Hou, Jun, Huang, Jie, Su, Jieakesu, Zeng, Haiying, Qin, Jing, Hou, Yingyong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5446751/ https://www.ncbi.nlm.nih.gov/pubmed/28549444 http://dx.doi.org/10.1186/s13000-017-0616-5 |
Ejemplares similares
-
Late stage gastric cancer patients with extra gained HER2 positivity by dual block assessment may not show compromised efficacy to trastuzumab treatment
por: Xu, Chen, et al.
Publicado: (2019) -
Poor efficacy response to trastuzumab therapy in advanced gastric cancer with homogeneous HER2 positive and non-intestinal type
por: Xu, Chen, et al.
Publicado: (2017) -
Dual block HER2 assessment increased HER2 immunohistochemistry positive rate in resected specimens of gastric cancer: a prospective multicenter clinical trial from China
por: Xu, Chen, et al.
Publicado: (2022) -
An alternative high output tissue microarray technique
por: Shi, Yuan, et al.
Publicado: (2013) -
Ideal number of biopsy tumor fragments for predicting HER2 status in gastric carcinoma resection specimens
por: Ahn, Sangjeong, et al.
Publicado: (2015)